TG THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tg Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Tg Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $12.4M, a 89.2% decline year-over-year.
  • Tg Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$505K, a 97.3% increase year-over-year.
  • Tg Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $20.6M.
  • Tg Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$193M, a 44.1% increase from 2021.
  • Tg Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$345M, a 26% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.6M +$213M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$193M +$152M +44.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$345M -$71.2M -26% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$274M -$105M -61.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$169M +$5.35M +3.07% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$174M -$55.7M -46.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$119M -$39.7M -50.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$79M -$15.8M -25% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$63.2M -$7.46M -13.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$55.7M -$32.8M -143% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$23M +$3.93M +14.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$26.9M -$26M -2949% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-07
2011 -$882K Jan 1, 2011 Dec 31, 2011 10-K 2013-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.